Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
228 results found
Apr 17, 2018
Presentation
Seasonal influenza
Data from Completed Phase 1/2 Trial of a Novel Recombinant Saponin-Adjuvanted tNIV
Vivek Shinde
Apr 4, 2018
Presentation
Seasonal influenza
Nanoparticle Influenza Vaccine: Older Adults

World Vaccine Congress

Apr 4, 2018
Presentation
RSV
RSV F Nanoparticle Vaccine: IVM

World Vaccine Congress

Mar 28, 2018
Publication
Collaborative
Immunologic Research
COVID-19, Matrix-M® adjuvant
Matrix-M adjuvant enhances immunogenicity of both protein- and modified vaccinia viru Ankara-based influenza vaccines in mice
Magnusson SE, Altenburg AF, Bengtsson KL et al.
Jan 11, 2018
Poster
RSV
Respiratory Syncytial Virus (RSV) Pre-fusogenic F Nanoparticle Vaccine Compared to Pre-fusion F and Post-fusion F Proteins

11th International Respiratory Syncytial Virus Symposium

Smith, Gale"
Jan 11, 2018
Poster
RSV
Feasibility Evaluation of Blow Fill Seal Process and Compatibility with Aluminum Phosphate Adjuvanted Recombinant RSV F Nanoparticle Vaccine

11th International Respiratory Syncytial Virus Symposium

Lin, Yen-Huei
Jan 11, 2018
Poster
RSV
Binding Kinetics of RSV Pre-fusogenic F Nanoparticle Vaccine to Palivizumab and Serum Polyclonal Antibody

11th International Respiratory Syncytial Virus Symposium

"Lu, Hanxin"
Jan 11, 2018
Poster
RSV
Antigenic Characterization of RSV Pre-fusogenic F Nanoparticle Vaccine, Pre-F, and Post-F Proteins against a Broad Range of Neutralizing Monoclonal Antibodies and Epitope Responses in Cotton Rats

11th International Respiratory Syncytial Virus Symposium

Patel, Nita
Sep 21, 2017
Publication
Collaborative
Vaccine
Malaria, Matrix-M® adjuvant
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
Venkatraman, Navin, Anagnostou, Nicholas , Bliss, Carly, et al.
Aug 22, 2017
Publication
Novavax led
Vaccine
Seasonal influenza, Matrix-M® adjuvant
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
Smith, Gale, Liu, Ye, Flyer, David, et al.